Cagent Vascular Inks $41M Series D Round

Deal Summary

Cagent Vascular, a leader in endovascular technologies, closed a $41 million Series D financing round co‑led by U.S. Venture Partners and Astoria Health Investors. The funds will support the REMODEL II pivotal trial and commercial launch of its SONIC IVL System, as well as further development of its angioplasty balloon platform.